GROWTH FORECAST (NASDAQ: HUGE) FSD Pharma's forecast annual revenue growth rate of 743.24% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 13.45%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 14.61%.
FSD Pharma's revenue in 2021 is $196,259.On average, 1 Wall Street analysts forecast HUGE's revenue for 2022 to be $117,623,272, with the lowest HUGE revenue forecast at $117,623,272, and the highest HUGE revenue forecast at $117,623,272. On average, 1 Wall Street analysts forecast HUGE's revenue for 2023 to be $470,571,400, with the lowest HUGE revenue forecast at $470,571,400, and the highest HUGE revenue forecast at $470,571,400.
In 2024, HUGE is forecast to generate $941,142,800 in revenue, with the lowest revenue forecast at $941,142,800 and the highest revenue forecast at $941,142,800.